Amendment # 1 to the Collaboration and Option AgreementCollaboration and Option Agreement • March 17th, 2014 • Globeimmune Inc • Pharmaceutical preparations
Contract Type FiledMarch 17th, 2014 Company IndustryThis is an Amendment (“Amendment”) to the Collaboration and Option Agreement dated May 14th 2009 (the “Agreement) by and between Celgene Corporation, a Delaware corporation having a place of business at 86 Morris Avenue, Summit, New Jersey 07901 (“Celgene”), and GlobeImmune, Inc., a Delaware corporation having a place of business at 1450 Infinite Drive, Louisville, Colorado 80027 (“GlobeImmune”).
Amendment # 1 to the Collaboration and Option AgreementCollaboration and Option Agreement • July 2nd, 2012 • Globeimmune Inc • Pharmaceutical preparations
Contract Type FiledJuly 2nd, 2012 Company IndustryThis is an Amendment (“Amendment”) to the Collaboration and Option Agreement dated May 14th 2009 (the “Agreement) by and between Celgene Corporation, a Delaware corporation having a place of business at 86 Morris Avenue, Summit, New Jersey 07901 (“Celgene”), and GlobeImmune, Inc., a Delaware corporation having a place of business at 1450 Infinite Drive, Louisville, Colorado 80027 (“GlobeImmune”).